Bernd Seizinger

Dr Seizinger has held a number of senior executive and board positions in both US and European biotech and pharmaceutical companies (public and private) including President & CEO of GPC Biotech (Germany/US) in addition to Vice President positions at Bristol-Myers-Squibb, CSO of Genome Therapeutics, CEO/Chairman of CryptoMedix, Chairman of Aprea and Opsona Therapeutics. Prior to his corporate appointments, Dr Seizinger held senior faculty positions at Harvard Medical School and Massachusetts General Hospital and was a Visiting Professor at Princeton University during his tenure at Bristol-Myers Squibb.